Methods and pharmaceutical compositions for preventing or reducing metastatic dissemination
US-9851358-B2 · Dec 26, 2017 · US
This page is not indexed by search engines while we improve data quality.
Inserm (Institut National De La Sante Et De La Rech Medicale) patents in 2017
Inserm (Institut National De La Sante Et De La Rech Medicale) was listed as an assignee on 9 patent publications in 2017.
| Metric | Value |
|---|---|
| Company | Inserm (Institut National De La Sante Et De La Rech Medicale) |
| Year | 2017 |
| Patents | 9 |
Patents
Representative publications for Inserm (Institut National De La Sante Et De La Rech Medicale) in 2017.
Molecular targets for the prevention and/or treatment of fibrosis, hypertrophic scars or keloids
US-9840704-B2 · Dec 12, 2017 · US
Transgenic rpe cells overexpressing otx2 for the treatment of retinal degeneration
US-2017348434-A1 · Dec 7, 2017 · US
Methods for the treatment and diagnosis of bone mineral density related diseases
US-9834820-B2 · Dec 5, 2017 · US
Methods for the prevention and the treatment of extracapillary glomerulonephritis
US-2017342415-A1 · Nov 30, 2017 · US
Top CPC classifications
Most common classification codes for Inserm (Institut National De La Sante Et De La Rech Medicale) in 2017.
| CPC | Patents |
|---|---|
| A61P43/00 | 3 |
| A61B5/4818 | 2 |
| A61B5/4836 | 2 |
| A61B5/6833 | 2 |
| A61B5/68335 | 2 |
Related pages
Navigate to parent entity pages.